{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:03:39Z","timestamp":1781049819354,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chonnam National University Hospital Biomedical Research Institute","award":["BCRI24035"],"award-info":[{"award-number":["BCRI24035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48062-9","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:55:17Z","timestamp":1776480917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma apolipoprotein M level and estimated glomerular filtration rate in type 2 diabetes patients with and without albuminuria"],"prefix":"10.1038","volume":"16","author":[{"given":"Jin Ook","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Baek","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitz-na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyeok","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Jin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Young","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"48062_CR1","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","volume":"1","author":"MC Thomas","year":"2015","unstructured":"Thomas, M. C. et al. Diabetic kidney disease. Nat. Rev. Dis. Primers. 1, 15018. https:\/\/doi.org\/10.1038\/nrdp.2015.18 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"48062_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1210\/endrev\/bnz010","volume":"41","author":"Y Lytvyn","year":"2020","unstructured":"Lytvyn, Y., Bjornstad, P., van Raalte, D. H., Heerspink, H. L. & Cherney, D. Z. I. The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications. Endocr. Rev. 41, 202\u2013231. https:\/\/doi.org\/10.1210\/endrev\/bnz010 (2020).","journal-title":"Endocr. Rev."},{"key":"48062_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semnephrol.2007.01.002","volume":"27","author":"D de Zeeuw","year":"2007","unstructured":"de Zeeuw, D. & Albuminuria A target for treatment of type 2 diabetic nephropathy. Semin Nephrol. 27, 172\u2013181. https:\/\/doi.org\/10.1016\/j.semnephrol.2007.01.002 (2007).","journal-title":"Semin Nephrol."},{"key":"48062_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jama.286.4.421","volume":"286","author":"HC Gerstein","year":"2001","unstructured":"Gerstein, H. C. et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Jama-J Am. Med. Assoc. 286, 421\u2013426. https:\/\/doi.org\/10.1001\/jama.286.4.421 (2001).","journal-title":"Jama-J Am. Med. Assoc."},{"key":"48062_CR5","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1681\/Asn.2008121270","volume":"20","author":"T Ninomiya","year":"2009","unstructured":"Ninomiya, T. et al. Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes. J. Am. Soc. Nephrol. 20, 1813\u20131821. https:\/\/doi.org\/10.1681\/Asn.2008121270 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"48062_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2337\/dc11-1380","volume":"35","author":"A Solini","year":"2012","unstructured":"Solini, A. et al. Diverging Association of Reduced Glomerular Filtration Rate and Albuminuria With Coronary and Noncoronary Events in Patients With Type 2 Diabetes The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. Diabetes Care. 35, 143\u2013149. https:\/\/doi.org\/10.2337\/dc11-1380 (2012).","journal-title":"Diabetes Care"},{"key":"48062_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s001250051151","volume":"42","author":"CE Mogensen","year":"1999","unstructured":"Mogensen, C. E. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 42, 263\u2013285. https:\/\/doi.org\/10.1007\/s001250051151 (1999).","journal-title":"Diabetologia"},{"key":"48062_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","volume":"63","author":"AI Adler","year":"2003","unstructured":"Adler, A. I. et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 63, 225\u2013232. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00712.x (2003).","journal-title":"Kidney Int."},{"key":"48062_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S2213-8587(","volume":"3","author":"E Porrini","year":"2015","unstructured":"Porrini, E. et al. Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes. Lancet Diabetes Endo. 3, 382\u2013391. https:\/\/doi.org\/10.1016\/S2213-8587( (2015). 15)00094\u2009\u2013\u20097.","journal-title":"Lancet Diabetes Endo"},{"key":"48062_CR10","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.2337\/dc19-0349","volume":"42","author":"D Vistisen","year":"2019","unstructured":"Vistisen, D. et al. Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria. Diabetes Care. 42, 1886\u20131894. https:\/\/doi.org\/10.2337\/dc19-0349 (2019).","journal-title":"Diabetes Care"},{"key":"48062_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.kint.2016.01.023","volume":"90","author":"CQF Klessens","year":"2016","unstructured":"Klessens, C. Q. F. et al. An autopsy study suggests that diabetic nephropathy is underdiagnosed. Kidney Int. 90, 149\u2013156. https:\/\/doi.org\/10.1016\/j.kint.2016.01.023 (2016).","journal-title":"Kidney Int."},{"key":"48062_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000500353","volume":"50","author":"G Comai","year":"2019","unstructured":"Comai, G. et al. Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis. Am. J. Nephrol. 50, 29\u201336. https:\/\/doi.org\/10.1159\/000500353 (2019).","journal-title":"Am. J. Nephrol."},{"key":"48062_CR13","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1074\/jbc.M704576200","volume":"283","author":"C Christoffersen","year":"2008","unstructured":"Christoffersen, C. et al. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. J. Biol. Chem. 283, 1839\u20131847. https:\/\/doi.org\/10.1074\/jbc.M704576200 (2008).","journal-title":"J. Biol. Chem."},{"key":"48062_CR14","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2337\/db21-0920","volume":"71","author":"NL Baker","year":"2022","unstructured":"Baker, N. L. et al. Plasma apoM Levels and Progression to Kidney Dysfunction in Patients With Type 1 Diabetes. Diabetes 71, 1795\u20131799. https:\/\/doi.org\/10.2337\/db21-0920 (2022).","journal-title":"Diabetes"},{"key":"48062_CR15","doi-asserted-by":"publisher","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","volume":"274","author":"N Xu","year":"1999","unstructured":"Xu, N. & Dahlback, B. A novel human apolipoprotein (apoM). J. Biol. Chem. 274, 31286\u201331290. https:\/\/doi.org\/10.1074\/jbc.274.44.31286 (1999).","journal-title":"J. Biol. Chem."},{"key":"48062_CR16","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1194\/jlr.M600055-JLR200","volume":"47","author":"C Christoffersen","year":"2006","unstructured":"Christoffersen, C. et al. Isolation and characterization of human apolipoprotein M-containing lipoproteins. J. Lipid Res. 47, 1833\u20131843. https:\/\/doi.org\/10.1194\/jlr.M600055-JLR200 (2006).","journal-title":"J. Lipid Res."},{"key":"48062_CR17","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1161\/Circresaha.109.211086","volume":"106","author":"C Christoffersen","year":"2010","unstructured":"Christoffersen, C. et al. Opposing Effects of Apolipoprotein M on Catabolism of Apolipoprotein B-Containing Lipoproteins and Atherosclerosis. Circ. Res. 106, 1624\u20131634. https:\/\/doi.org\/10.1161\/Circresaha.109.211086 (2010).","journal-title":"Circ. Res."},{"key":"48062_CR18","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1073\/pnas.1103187108","volume":"108","author":"C Christoffersen","year":"2011","unstructured":"Christoffersen, C. et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc. Natl. Acad. Sci. U S A. 108, 9613\u20139618. https:\/\/doi.org\/10.1073\/pnas.1103187108 (2011).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"48062_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246273","author":"EMG Diarte-Anazco","year":"2019","unstructured":"Diarte-Anazco, E. M. G. et al. Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20246273 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"48062_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/jdi.12232","volume":"5","author":"T Nojiri","year":"2014","unstructured":"Nojiri, T. et al. Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice. J. Diabetes Investig. 5, 639\u2013648. https:\/\/doi.org\/10.1111\/jdi.12232 (2014).","journal-title":"J. Diabetes Investig"},{"key":"48062_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cca.2017.01.006","volume":"466","author":"PH Zhang","year":"2017","unstructured":"Zhang, P. H. et al. ApoM\/HDL-C and apoM\/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus. Clin. Chim. Acta. 466, 31\u201337. https:\/\/doi.org\/10.1016\/j.cca.2017.01.006 (2017).","journal-title":"Clin. Chim. Acta"},{"key":"48062_CR22","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.clinbiochem.2015.08.001","volume":"48","author":"S Bekpinar","year":"2015","unstructured":"Bekpinar, S. et al. The effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes. Clin. Biochem. 48, 1264\u20131267. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.08.001 (2015).","journal-title":"Clin. Biochem."},{"key":"48062_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/MNH.0b013e3283456546","volume":"20","author":"RJ Macisaac","year":"2011","unstructured":"Macisaac, R. J. & Jerums, G. Diabetic kidney disease with and without albuminuria. Curr. Opin. Nephrol. Hypertens. 20, 246\u2013257. https:\/\/doi.org\/10.1097\/MNH.0b013e3283456546 (2011).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"48062_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ki.2009.399","volume":"77","author":"BA Perkins","year":"2010","unstructured":"Perkins, B. A., Ficociello, L. H., Roshan, B., Warram, J. H. & Krolewski, A. S. In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int. 77, 57\u201364. https:\/\/doi.org\/10.1038\/ki.2009.399 (2010).","journal-title":"Kidney Int."},{"key":"48062_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/Mol.0000000000000654","volume":"31","author":"G Tavernier","year":"2020","unstructured":"Tavernier, G., Caspar-Bauguil, S., Viguerie, N. & Apolipoprotein, M. new connections with diet, adipose tissue and metabolic syndrome. Curr. Opin. Lipidol. 31, 8\u201314. https:\/\/doi.org\/10.1097\/Mol.0000000000000654 (2020).","journal-title":"Curr. Opin. Lipidol."},{"key":"48062_CR26","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.12659\/MSM.907744","volume":"24","author":"T Li","year":"2018","unstructured":"Li, T., Yang, L., Zhao, S. & Zhang, S. Correlation Between Apolipoprotein M and Inflammatory Factors in Obese Patients. Med. Sci. Monit. 24, 5698\u20135703. https:\/\/doi.org\/10.12659\/MSM.907744 (2018).","journal-title":"Med. Sci. Monit."},{"key":"48062_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2021.08.039","volume":"334","author":"I Yao Mattisson","year":"2021","unstructured":"Yao Mattisson, I. & Christoffersen, C. Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system. Atherosclerosis 334, 76\u201384. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.08.039 (2021).","journal-title":"Atherosclerosis"},{"key":"48062_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1056\/NEJM199910073411506","volume":"341","author":"E Ritz","year":"1999","unstructured":"Ritz, E. & Orth, S. R. Nephropathy in patients with type 2 diabetes mellitus. N Engl. J. Med. 341, 1127\u20131133. https:\/\/doi.org\/10.1056\/NEJM199910073411506 (1999).","journal-title":"N Engl. J. Med."},{"key":"48062_CR29","doi-asserted-by":"publisher","first-page":"158969","DOI":"10.1016\/j.bbalip.2021.158969","volume":"1866","author":"S Hajny","year":"2021","unstructured":"Hajny, S., Borup, A., Elsoe, S. & Christoffersen, C. Increased plasma apoM levels impair triglyceride turnover in mice. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids. 1866, 158969. https:\/\/doi.org\/10.1016\/j.bbalip.2021.158969 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"48062_CR30","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1194\/jlr.M700113-JLR200","volume":"48","author":"O Axler","year":"2007","unstructured":"Axler, O., Ahnstrom, J. & Dahlback, B. An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma. J. Lipid Res. 48, 1772\u20131780. https:\/\/doi.org\/10.1194\/jlr.M700113-JLR200 (2007).","journal-title":"J. Lipid Res."},{"key":"48062_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12944-016-0246-z","volume":"15","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications. Lipids Health Dis. 15, 76. https:\/\/doi.org\/10.1186\/s12944-016-0246-z (2016).","journal-title":"Lipids Health Dis."},{"key":"48062_CR32","doi-asserted-by":"publisher","first-page":"730","DOI":"10.5551\/jat.55699","volume":"28","author":"T Kobayashi","year":"2021","unstructured":"Kobayashi, T. et al. Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate. J. Atheroscler Thromb. 28, 730\u2013741. https:\/\/doi.org\/10.5551\/jat.55699 (2021).","journal-title":"J. Atheroscler Thromb."},{"key":"48062_CR33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/ATVBAHA.115.307049","volume":"36","author":"JW Brinck","year":"2016","unstructured":"Brinck, J. W. et al. Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection. Arterioscler. Thromb. Vasc Biol. 36, 817\u2013824. https:\/\/doi.org\/10.1161\/ATVBAHA.115.307049 (2016).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"48062_CR34","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jmb.2009.08.071","volume":"393","author":"M Sevvana","year":"2009","unstructured":"Sevvana, M. et al. Serendipitous Fatty Acid Binding Reveals the Structural Determinants for Ligand Recognition in Apolipoprotein M. J. Mol. Biol. 393, 920\u2013936. https:\/\/doi.org\/10.1016\/j.jmb.2009.08.071 (2009).","journal-title":"J. Mol. Biol."},{"key":"48062_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2011.11.031","volume":"221","author":"S Elsoe","year":"2012","unstructured":"Elsoe, S. et al. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL. Atherosclerosis 221, 91\u201397. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.11.031 (2012).","journal-title":"Atherosclerosis"},{"key":"48062_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tem.2008.11.003","volume":"20","author":"LB Nielsen","year":"2009","unstructured":"Nielsen, L. B., Christoffersen, C., Ahnstrom, J. & Dahlback, B. ApoM: gene regulation and effects on HDL metabolism. Trends Endocrinol. Metab. 20, 66\u201371. https:\/\/doi.org\/10.1016\/j.tem.2008.11.003 (2009).","journal-title":"Trends Endocrinol. Metab."},{"key":"48062_CR37","doi-asserted-by":"publisher","first-page":"754490","DOI":"10.3389\/fmed.2021.754490","volume":"8","author":"LS Bisgaard","year":"2021","unstructured":"Bisgaard, L. S. & Christoffersen, C. The apoM\/S1P Complex-A Mediator in Kidney Biology and Disease? Front. Med. (Lausanne). 8, 754490. https:\/\/doi.org\/10.3389\/fmed.2021.754490 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"48062_CR38","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1007\/s10753-025-02303-7","volume":"48","author":"M Ahmed","year":"2025","unstructured":"Ahmed, M. et al. From Homeostasis To Inflammation To Autoimmunity: The Potential Impact of CRP. Inflammation 48, 3747\u20133762. https:\/\/doi.org\/10.1007\/s10753-025-02303-7 (2025).","journal-title":"Inflammation"},{"key":"48062_CR39","doi-asserted-by":"publisher","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","volume":"312","author":"R Pichler","year":"2017","unstructured":"Pichler, R., Afkarian, M., Dieter, B. P. & Tuttle, K. R. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. Am. J. Physiol. Ren. Physiol. 312, F716\u2013F731. https:\/\/doi.org\/10.1152\/ajprenal.00314.2016 (2017).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"48062_CR40","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2008-2534","volume":"94","author":"RB Goldberg","year":"2009","unstructured":"Goldberg, R. B. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J. Clin. Endocrinol. Metab. 94, 3171\u20133182. https:\/\/doi.org\/10.1210\/jc.2008-2534 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"48062_CR41","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1210\/jc.2003-030742","volume":"88","author":"TK Hansen","year":"2003","unstructured":"Hansen, T. K. et al. Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 88, 4857\u20134861. https:\/\/doi.org\/10.1210\/jc.2003-030742 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"48062_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199664","author":"C Secondulfo","year":"2025","unstructured":"Secondulfo, C. et al. Apolipoproteins in Chronic Kidney Disease and Kidney Transplant: A Long Unfinished Story. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms26199664 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"48062_CR43","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/ATVBAHA.124.322367","volume":"45","author":"JT Stadler","year":"2025","unstructured":"Stadler, J. T. et al. ApoM and Major Adverse Cardiovascular Events in Chronic Kidney Disease: A Prospective Cohort Study. Arterioscler. Thromb. Vasc Biol. 45, 496\u2013505. https:\/\/doi.org\/10.1161\/ATVBAHA.124.322367 (2025).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"Suppl 1","key":"48062_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/diacare.26.2007.s5","volume":"26","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2003","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 26 (Suppl 1), 5\u201320. https:\/\/doi.org\/10.2337\/diacare.26.2007.s5 (2003).","journal-title":"Diabetes Care"},{"key":"48062_CR45","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1515\/Cclm.2010.318","volume":"48","author":"A Grubb","year":"2010","unstructured":"Grubb, A. et al. First certified reference material for cystatin C in human serum ERM-DA471\/IFCC. Clin. Chem. Lab. Med. 48, 1619\u20131621. https:\/\/doi.org\/10.1515\/Cclm.2010.318 (2010).","journal-title":"Clin. Chem. Lab. Med."},{"key":"48062_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker, L. A. et al. Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C. New. Engl. J. Med. 367, 20\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1114248 (2012).","journal-title":"New. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48062-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48062-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48062-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:53:27Z","timestamp":1781049207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48062-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48062"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48062-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17960"}}